🔗 Share this article

A shadow market for unlicensed slimming medications is being driven by social media fitness personalities and vendors on communication apps, according to new investigations.

Investigational Drug Acquiring Traction Via Social Media

Retatrutide, which is still in research studies, is being advertised by online personalities for its alleged fat-burning effects. Viewers are encouraged to contact these profiles privately for source information, while also receiving promotional offers.

Thriving Trade on Messaging Platforms

Additionally, a robust trade exists on Telegram, where groups with thousands of participants share “before and after” photos, injection guides and claims of rapid UK delivery. Vendors market the substance there before redirecting customers to other platforms for transactions.

Learning About Retatrutide

Retatrutide is an investigational injectable created by American pharmaceutical company Eli Lilly. The treatment targets three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies suggest it could help patients reduce up to 25% of their body weight. Referred to as the “triple G”, the substance is being promoted digitally as the next Ozempic.

Healthcare Experts Voice Worries

However, physicians and pharmacists have cautions that the distribution of what is still an unlicensed medication in the United Kingdom is a cause for concern and could result in individuals administering substances of unknown origin.

Some experts said the demand for the experimental drug could be connected to the rising cost of approved weight loss products such as Mounjaro.

Legal Status and Implementation

Selling retatrutide on social media or messaging apps is prohibited in the UK, as it is an unapproved medication that must not be marketed or supplied for personal consumption under the Human Medicines Regulations 2012.

Several content creators try to sidestep the regulations by referring to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled drug, but advertising and distribution can still violate pharmaceutical, marketing, and consumer regulations, potentially leading to penalties, legal action or imprisonment.

Service Reaction and Material Elimination

According to TikTok, the service has taken down violative material and banned related hashtags and query recommendations. The organization said it was dedicated to keeping the service safe and allocating resources in strengthening enforcement strategies.

Online Marketplace Operations

Research also discovered communities with up to 9,000 members marketing the experimental drug using Telegram's integrated search feature, which functions like a public directory. Entering “retatrutide” immediately brings up groups with numerous of users, filled with images of slimming results, glowing testimonials and detailed guides for mixing or injecting at home.

Within minutes of entering one group, a seller shared contact information, where the majority of purchases occur. The seller sent an guidebook and guaranteed shipping within two days. When questioned whether the substance was genuine, one vendor said: “You can’t be sure.” Another shared a photo of a supposed laboratory certificate. Not one inquired about body mass, medical conditions or previous experience.

Item Information and Pricing

Within these communities, posts display dark colored packages with Royal Mail labels, claiming to contain fresh supplies. One message stated: “It took eight of us to load them this morning.”

Customers can choose between dry substance containers, mixed at home with sterile water, or pre-filled injectors typically sold at £160 for 20 milligrams. When asked how long a injector should last, vendors give contradictory responses ranging from a several days to “depends on your body”.

Service Oversight and Safety Actions

A representative for the messaging service said it actively monitored dangerous material on its service including material that encouraged the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.

Healthcare Professional Warnings

“Individuals are injecting materials they cannot confirm. Although the science behind this drug is valid, these online versions may not include what they advertise,” said Jason Murphy, the director of pharmaceutical services at a pharmacy service.

Dr Crystal Wyllie of Asda Online Doctor linked the surge in interest to current price rises for authorized slimming drugs such as Mounjaro. “With prices increasing, individuals are using online platforms. But counterfeit treatments are highly dangerous. You can’t be certain what’s inside or whether the environment they were made in was sterile,” she said.

Her team has previously seen patients harmed by self-injection from unverified suppliers. “We recognize the frustration, but buying from messaging apps or communication platforms is gambling with your health,” said Wyllie. “These materials could be impure or incorrectly dosed.”

Manufacturer Position

A representative from Eli Lilly stated retatrutide was in third stage clinical trials and had not been reviewed or authorized by any government authority anywhere in the world. “Therefore at this point no one can market [it] for human use,” they said, noting that any item “falsely representing itself as a Lilly experimental substance not yet approved … may expose users to possibly serious health risks”.